KMC Speciality Hospitals (India) Ltd

Event Overview

• Revision to encumbrance disclosures for promoter shares; rectified prior event holdings and added lender and trustee names.

AGM Details

• Date, time, mode: 28 September 2026, 10:30 IST, via VC/OAVM.
• Record date for voting: 21 September 2026.
• Attendance: promoter group 1 and public 59 via VC.

Key Resolutions

• Resolution 1: Adopt Audited Financial Statements for year ended 31 March 2026.
• Resolution 2: Re-appointment of Dr. S. Vijayabaskaran, retiring by rotation.
• Resolution 3: Approve Material Related Party Transaction with Sri Kauvery Medical Care (India) Limited.
• Resolution 4: Ratify remuneration to Cost Auditor for 2026-27.
• Resolution 5: Borrowing limits under Sections 180(1)(c) and 180(1)(a).

Voting Results

• Resolution 1 passed with 99.9999% in favour.
• Resolution 2 passed with 99.9823% in favour.
• Resolution 3 passed with 99.9934% in favour.
• Resolution 4 passed with 99.9999% in favour.
• Resolution 5 passed with 99.9819% in favour.

Director Changes

• Director changes: Dr. S. Vijayabaskaran re-appointed (retires by rotation).

Auditors / Remuneration

• Cost Auditor remuneration ratified for the financial year 2026-27.

Material Related Party Transactions

• Approved related party transaction with Sri Kauvery Medical Care (India) Limited (Holding Company).

KMC Speciality Hospitals (India) Ltd - Trading Window closed from 01 October 2026 till 48 hours after the declaration of Unaudited financial results for the quarter and half year ending 30th September, 2026

AGM Details

• Date and time: 28 September 2026, 10:30 AM, via Video Conferencing/OAVM.
• Meeting concluded at 11:06 AM.
• Meeting conducted through VC/OAVM as per MCA/SEBI guidelines.

Key Resolutions

• Adopt Audited Financial Statements for FY2026 (Ordinary).
• Re-appoint Dr. S Vijayabaskaran by rotation (Ordinary).
• Approve Material Related Party Transactions with Holding Company (Special).
• Ratify remuneration to Cost Auditor for FY2026-27 (Ordinary).
• Approve borrowing limits under section 180(1)(c) and 180(1)(a) (Special).

Voting Update

• Resolutions were voted via remote e-voting; no on-site voting at AGM.
• Consolidated results to be announced within two working days.
• Results to be uploaded on company, evoting, and stock exchange websites.

Auditors & RPT Disclosures

• Statutory Auditors: Deloitte Haskins & Sells presented at the AGM.
• Secretarial Auditor: Alagar & Associates LLP acted as Scrutinizer.
• Cost Auditor remuneration ratification for FY2026-27 approved.
• Material Related Party Transactions with Sri Kauvery Medical Care (India) Limited disclosed.

Event Overview

• Creation of pledge/NDU on promoter shares in favour of Catalyst Trusteeship Limited.

Key Details

• Target company is KMC Speciality Hospitals (India) Ltd.
• Encumbrance type is pledge and non-disposal undertaking (NDU).
• Pre-event encumbered shares were Nil.
• Post-event encumbered shares are updated; specific number is not disclosed.
• Promoter/group is Sri Kauvery Medical Care (India) Limited.
• Encumbrance is in favour of Catalyst Trusteeship Limited for debenture holders.
• Reason for encumbrance will be specified in revised disclosure.
• Date of revised disclosure submission is 15 September 2026.
• Amount/facility size is not disclosed.
• Impact on promoter holding is not disclosed.
• End use of funds is not specified.

Encumbrance on promoter shares

• Creation of indirect encumbrance: pledge over SKMCIL shares.
• 27,41,435 SKMCIL shares encumbered (5.37% of SKMCIL fully diluted).
• Promoter: Sri Kauvery Medical Care (India) Limited (SKMCIL).
• Encumbrance in favour of: Catalyst Trusteeship Limited (Debenture Trustee).
• Reason: to secure debentures issued to Prospera Healthcorp Private Limited.
• Date of creation: September 4, 2026.

Overview

• Standalone BRSR for FY2025-26 covering hospital services.
• Main activity: Hospital and Medical Care Services with 100% turnover from hospitals.
• Reporting boundary is standalone; two Tiruchirappalli hospital units and two offices.
• Domestic locations: two hospital units in Tamil Nadu; no international sites.
• CSR turnover and net worth disclosed: Rs 305,76,81,694 and Rs 210,42,88,007.
• Paid-up capital: Rs 16,30,85,000.
• BRSR plus annual report; assurance not applicable.

Key ESG Risks & Opportunities

• Privacy and cybersecurity risk from patient data; mitigated with encryption, access controls, audits.
• Labor-management risk from attrition; mitigated via KLIFT, KLIFE, KTT leadership programs.
• Supply chain risk due to material shortages; mitigated through robust logistics and supplier contracts.
• Renewable energy share reached 92% in FY26; target 100% from FY26-27.
• LEED Silver and Green Hospital recognitions reinforce sustainability credentials.
• Opportunities include expanding affordable healthcare access and strengthening reputation.

Governance & Policy Highlights

• BR performance reviewed by management; Board oversight via Risk Management Committee.
• CSR Committee governs CSR; Stakeholder Relationship Committee handles grievances.
• Policies include whistleblower, POSH, equal opportunity, and prohibition of child labour.
• No material penalties or regulatory fines reported.
• Assurance: Not applicable; external assurance not engaged.

Social Responsibility & Workforce

• Total employees 1,742; permanent 1,695; female permanent 1,324.
• Board female representation 12.5%; KMP female representation 20%.
• Turnover for permanent employees around 32% in FY25-26.
• 100% health insurance for employees and dependents; free medical checkups.
• Leadership development: KLIFT, KLIFE, KTT; ongoing skill upgrades.
• Premises accessible to differently abled; DEI policy in place.
• Grievance mechanism: digital HR portal and 24/7 platform.
• POSH Internal Complaints Committee; no POSH complaints reported.
• NABH accreditation and ISO 27001:2022 achieved at key units.

Environmental Performance

• Total energy: 15,146,643.60 MJ; renewable energy share 92% in FY26.
• GHG: Scope 2 emissions 292 tCO2e; Scope 1 nil.
• Energy intensity: 538.36 MJ per Rs 1 Lakh turnover; PPP-adjusted 10950.
• Water withdrawals: 225,668 kilolitres; rainwater harvesting across facilities.
• Waste: total 343 tonnes; BMW 98; plastic 148; CDW 91.
• Certifications: LEED Silver, NABH Full Accreditation, ISO 27001:2022, 5S Platinum.
• Wastewater treated/reused via STP/ETP; no zero-liquid-discharge. External assessments by ABC Techno Labs for water/air.

Stakeholder Engagement & Complaints

• Key stakeholder groups: customers/patients, suppliers, investors, community, regulators, employees.
• Engagement channels: in-person, phone, email, website; frequency: throughout the year.
• Customer complaints filed: 1,955; all resolved during year.
• Shareholder complaints: 13; none pending; resolved.
• Grievance platforms: SCORES for investors; 24/7 platform for patients.
• POSH complaints: none reported.
• Community health camps and CSR initiatives support marginalized groups.

Other Notable Metrics

• Related party transactions: purchases from top trading houses 8%; related-party sales 4%.
• MSME procurement: 17% directly from MSMEs; 100% Indian suppliers.
• Workforce geography: Rural 30%, Semi-urban 25%, Urban 25%, Metropolitan 20%.
• Gross wages paid to females: 64% of total (FY25-26); 63% (FY24-25).
• Conflict-of-interest disclosures collected; related-party transactions conducted at arm's length.

Financial highlights

• Revenue from operations: Rs 305.8 Cr in FY2025-26.
• EBITDA: Rs 93.0 Cr; margin uplift.
• PAT: Rs 46.7 Cr; YoY rise of 118%.
• Dividend: no dividend declared for FY2025-26.
• Total assets: Rs 332.12 Cr; equity: Rs 210.43 Cr.
• Total borrowings: Rs 71.03 Cr (net of cash).
• Cash & cash equivalents: Rs 50.02 Cr.
• EMR adoption: 87.63%.
• Renewable energy share: 92%.
• Employees on roll: 1,695; 533 joined during year.
• ABHA IDs created: 3,853; Radiology reports: 43,817.
• Patients served: 170,145; Inpatients 18,737; Surgeries 7,477.
• Deliveries: 826; Center of Excellence for Liver Transplant & Bone Marrow Transplant.
• Two-hospital network: 450 beds (250 Cantonment, 200 Maa Kauvery).
• Da Vinci robotic system deployed; robotics in surgery expanding.

Operations & capacity

• 450-bed platform across two Trichy hospitals (250 Cantonment, 200 Maa Kauvery).
• Integrated care network enabling diverse specialty services.
• Centre of Excellence: Liver transplant; Bone marrow transplant; Multidisciplinary care.
• Robotics and advanced procedures expanding surgical capacity.
• Interventional Radiology activity rose to 117 procedures across 13 types.
• Exclusive Burns Unit and Kauvery Rehabilitation Centre established.
• Deliveries and neonatal care show capability for high-risk pregnancies.
• Waste and energy initiatives include 92% renewables; LEED Silver Maa Kauvery; 2-acre afforestation site.

Technology & digital

• EMR adoption at 87.63%; Connected Healthcare monitored 972 patients.
• AI-enabled discharge summaries; ICU risk classification; predictive scoring.
• Digital ICU and Life Signs monitoring; AI in clinical workflows.
• Oracle Fusion ERP implemented for finance and procurement; Pharmacy procurement ERP in place.
• Automation across BMS, invoicing, card verification; time savings realized.

ESG & sustainability

• Renewable energy share 92%; 100% target from next financial year.
• LEED Silver rating for Maa Kauvery; NABH Digital Health awards.
• 100% renewable energy transition in near term; waste management and water reuse.
• Great Place to Work certification; gender diversity; employee well-being programs.
• Information security: ISO 27001:2022; data privacy measures; ethical governance.

Governance & risk

• Board: 8 members; 50% Independent; 1 woman Independent director.
• KMP changes: Indumathi P appointed; Sushma K resigned.
• Statutory auditors: Deloitte Haskins & Sells; Internal: Grant Thornton.
• Material Related Party Transactions with SKMC up to Rs 65 Cr for FY2026-27.
• SS 2/SEBI LODR compliance; Secretarial audit by Alagar & Associates.

Capital structure & liquidity

• Total assets Rs 332.12 Cr; equity Rs 210.43 Cr.
• Total borrowings Rs 71.03 Cr; liquidity comfortable.
• Cash & cash equivalents Rs 50.02 Cr; dematerialization framework in place.
• Dividend declared: none; no fresh equity issued; AGM planned.

Related-party transactions & audit

• Material RPT with SKMC approved; aggregate limit Rs 65 Cr for FY2026-27.
• RPT categories include hospital services, purchases, lab, imaging, rentals, guarantees, reimbursements.
• RPT disclosures aligned with SEBI LODR industry standards; arm's length basis.

Outlook & risks

• Indian private healthcare to grow with increasing insurance coverage and digital health adoption.
• Expansion plans include Maa Kauvery expansion by 100 beds and Bengaluru centre.

Business Overview

• 450-bed multi-speciality hospital in Tiruchirapalli with 200-bed Mother & Child facility added Jan 2024.
• Group Sri Kauvery Medical Care owns 75% of KMC Specialty Hospitals.
• Center-focused on Mother & Child, Neuro, Gastro, Orthopedics, Plastic Surgery, and Transplants.
• NABH accreditation; strong digital ecosystem; academic enablement with 59 DnB seats.
• IP mix concentrated in Tiruchirapalli region ~89%.

Operational Highlights

• Q1 FY'27 Total Income: INR 93.6 cr; YoY growth 38.9%.
• Q1 FY'27 EBITDA: INR 30.3 cr; margin 32.4%.
• Q1 FY'27 PAT: INR 16.6 cr; margin 17.7%.
• Capacity expansion: Legacy block 250 beds; New block 200 beds.
• Centers of Excellence focusing on key specialties.
• Academic enablement with 59 DnB seats; NABH accreditation.

Financial Performance

• FY26 Revenue from operations INR 305.8 cr; YoY +32%.
• FY26 Total Income INR 310.8 cr; YoY +32.5%.
• FY26 EBITDA INR 93.0 cr; margin 29.9%.
• FY26 PAT INR 46.7 cr; margin 15%.
• Q1 FY'27 Total Income INR 93.6 cr; EBITDA INR 30.3 cr; PAT INR 16.6 cr.
• Q1 FY'27 EBITDA margin 32.4%; PAT margin 17.7%.
• Net cash from operating activities: Q1 FY'27 INR 27.31 cr.

Liquidity & Capital Structure

• Cash & equivalents: INR 69.49 cr as of 30 Jun 2026.
• Total equity: INR 226.84 cr; Debt/Equity: 0.30x.
• Borrowings: Non-current INR 58.70 cr; Current INR 9.60 cr.
• Lease liabilities: Non-current INR 10.10 cr; Current INR 4.42 cr.
• Trade payables: INR 16.78 cr; Other current liabilities INR 6.92 cr.
• Net debt negative; Net Debt/EBITDA zero.

Strategic Priorities & Outlook

• Sustainable Growth Strategy emphasizing capacity expansion and talent engagement.
• Doctors Engagement Model aimed at attracting and retaining clinical talent.
• Expansion across centers with advanced infrastructure and digital enablement.
• Academic enablement to support clinical excellence.

Governance & Leadership

• Board includes founder-executive chairman and MD; two non-exec directors; four independent directors.
• Group promoters maintain major stake; parent owns 75% of KMC Specialty Hospitals.